MANNKIND CORP Increase (Decrease) in Other Operating Assets
MANNKIND CORP (MNKD) reported Increase (Decrease) in Other Operating Assets of -$2.03 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2026-08-05
- MANNKIND CORP increase (decrease) in other operating assets for the quarter ending 2026-06-30 was -$4.45M.
- MANNKIND CORP increase (decrease) in other operating assets for the quarter ending 2026-03-31 was $2.42M, a 45.45% increase year-over-year.
- MANNKIND CORP increase (decrease) in other operating assets for the quarter ending 2025-12-31 was $383.00K, a 48.87% decline year-over-year.
- MANNKIND CORP increase (decrease) in other operating assets for the quarter ending 2025-09-30 was $1.00K, a 99.84% decline year-over-year.
- MANNKIND CORP increase (decrease) in other operating assets for fiscal 2025 was $1.91M, a 46.53% decline from fiscal 2024.
- MANNKIND CORP increase (decrease) in other operating assets for fiscal 2024 was $3.57M.
- MANNKIND CORP increase (decrease) in other operating assets for fiscal 2023 was -$263.00K.
- MANNKIND CORP increase (decrease) in other operating assets for fiscal 2022 was -$523.00K, a 478.99% decline from fiscal 2021.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 6 month as first filed | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 9 month as first filed | Increase (Decrease) in Other Operating Assets 12 month | Increase (Decrease) in Other Operating Assets 244 month | Increase (Decrease) in Other Operating Assets 247 month | Increase (Decrease) in Other Operating Assets 250 month | Increase (Decrease) in Other Operating Assets 253 month | Increase (Decrease) in Other Operating Assets 256 month | Increase (Decrease) in Other Operating Assets 259 month | Increase (Decrease) in Other Operating Assets 263 month | Increase (Decrease) in Other Operating Assets 265 month | Increase (Decrease) in Other Operating Assets 268 month | Increase (Decrease) in Other Operating Assets 271 month | Increase (Decrease) in Other Operating Assets 275 month | Increase (Decrease) in Other Operating Assets 277 month | Increase (Decrease) in Other Operating Assets 280 month | Increase (Decrease) in Other Operating Assets 283 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$4.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$2.03M 10-Q · filed 2026-08-05 | -$1.65M derived: sum of 3 quarters · filed 2026-08-05 | -$1.65M derived: sum of 4 quarters · filed 2026-08-05 | ||||||||||||||||
| 2026-03-31 | $2.42M 10-Q · filed 2026-05-06 | $2.80M derived: sum of 2 quarters · filed 2026-05-06 | $2.80M derived: sum of 3 quarters · filed 2026-05-06 | $2.66M derived: sum of 4 quarters · filed 2026-08-05 | ||||||||||||||||
| 2025-12-31 | $383.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $384.00K derived: sum of 2 quarters · filed 2026-02-26 | $248.00K derived: sum of 3 quarters · filed 2026-08-05 | $1.91M 10-K · filed 2026-02-26 | ||||||||||||||||
| 2025-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$135.00K derived: sum of 2 quarters · filed 2026-08-05 | $1.53M 10-Q · filed 2025-11-05 | $2.27M derived: sum of 4 quarters · filed 2026-08-05 | ||||||||||||||||
| 2025-06-30 | -$136.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $1.52M 10-Q · filed 2026-08-05 | $2.27M derived: sum of 3 quarters · filed 2026-08-05 | $2.89M derived: sum of 4 quarters · filed 2026-08-05 | ||||||||||||||||
| 2025-03-31 | $1.66M 10-Q · filed 2026-05-06 | $2.41M derived: sum of 2 quarters · filed 2026-05-06 | $3.02M derived: sum of 3 quarters · filed 2026-05-06 | $4.92M derived: sum of 4 quarters · filed 2026-05-06 | ||||||||||||||||
| 2024-12-31 | $749.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.36M derived: sum of 2 quarters · filed 2026-02-26 | $3.26M derived: sum of 3 quarters · filed 2026-02-26 | $3.57M 10-K · filed 2026-02-26 | ||||||||||||||||
| 2024-09-30 | $612.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $2.51M derived: sum of 2 quarters · filed 2025-11-05 | $2.82M 10-Q · filed 2025-11-05 | $2.52M derived: sum of 4 quarters · filed 2026-02-26 | ||||||||||||||||
| 2024-06-30 | $1.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $2.21M 10-Q · filed 2025-08-06 | $1.91M derived: sum of 3 quarters · filed 2026-02-26 | $1.93M derived: sum of 4 quarters · filed 2026-02-26 | ||||||||||||||||
| 2024-03-31 | $314.00K 10-Q · filed 2025-05-08 | $16.00K derived: sum of 2 quarters · filed 2026-02-26 | $31.00K derived: sum of 3 quarters · filed 2026-02-26 | |||||||||||||||||
| 2023-12-31 | -$298.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$283.00K derived: sum of 2 quarters · filed 2026-02-26 | -$263.00K 10-K · filed 2026-02-26 | |||||||||||||||||
| 2023-09-30 | $15.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $35.00K 10-Q · filed 2024-11-07 | ||||||||||||||||||
| 2023-06-30 | $20.00K 10-Q · filed 2024-08-07 | |||||||||||||||||||
| 2022-12-31 | -$1.09M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | -$964.00K derived: sum of 2 quarters · filed 2025-02-26 | -$843.00K derived: sum of 3 quarters · filed 2025-02-26 | -$523.00K 10-K · filed 2025-02-26 | ||||||||||||||||
| 2022-09-30 | $127.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $248.00K derived: sum of 2 quarters · filed 2023-11-07 | $568.00K 10-Q · filed 2023-11-07 | $267.00K derived: sum of 4 quarters · filed 2024-02-27 | ||||||||||||||||
| 2022-06-30 | $121.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $441.00K 10-Q · filed 2023-08-07 | $140.00K derived: sum of 3 quarters · filed 2024-02-27 | $377.00K derived: sum of 4 quarters · filed 2024-02-27 | ||||||||||||||||
| 2022-03-31 | $320.00K 10-Q · filed 2023-05-09 | $19.00K derived: sum of 2 quarters · filed 2024-02-27 | $256.00K derived: sum of 3 quarters · filed 2024-02-27 | $361.00K derived: sum of 4 quarters · filed 2024-02-27 | ||||||||||||||||
| 2021-12-31 | -$301.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$64.00K derived: sum of 2 quarters · filed 2024-02-27 | $41.00K derived: sum of 3 quarters · filed 2024-02-27 | $138.00K 10-K · filed 2024-02-27 | ||||||||||||||||
| 2021-09-30 | $237.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $342.00K derived: sum of 2 quarters · filed 2022-11-08 | $439.00K 10-Q · filed 2022-11-08 | $403.00K derived: sum of 4 quarters · filed 2023-02-23 | ||||||||||||||||
| 2021-06-30 | $105.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $202.00K 10-Q · filed 2022-08-09 | $166.00K derived: sum of 3 quarters · filed 2023-02-23 | $57.00K derived: sum of 4 quarters · filed 2023-02-23 | ||||||||||||||||
| 2021-03-31 | $97.00K 10-Q · filed 2022-05-05 | $61.00K derived: sum of 2 quarters · filed 2023-02-23 | -$48.00K derived: sum of 3 quarters · filed 2023-02-23 | -$90.00K derived: sum of 4 quarters · filed 2023-02-23 | ||||||||||||||||
| 2020-12-31 | -$36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | -$145.00K derived: sum of 2 quarters · filed 2023-02-23 | -$187.00K derived: sum of 3 quarters · filed 2023-02-23 | -$227.00K 10-K · filed 2023-02-23 | ||||||||||||||||
| 2020-09-30 | -$109.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$151.00K derived: sum of 2 quarters · filed 2021-11-09 | -$191.00K 10-Q · filed 2021-11-09 | $2.00K derived: sum of 4 quarters · filed 2021-11-09 | ||||||||||||||||
| 2020-06-30 | -$42.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | -$82.00K 10-Q · filed 2021-08-11 | $111.00K derived: sum of 3 quarters · filed 2021-08-11 | $111.00K derived: sum of 4 quarters · filed 2021-08-11 | ||||||||||||||||
| 2020-03-31 | -$40.00K 10-Q · filed 2021-05-12 | $153.00K derived: sum of 2 quarters · filed 2021-05-12 | $153.00K derived: sum of 3 quarters · filed 2021-05-12 | $169.00K derived: sum of 4 quarters · filed 2021-05-12 | ||||||||||||||||
| 2019-12-31 | $193.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $193.00K derived: sum of 2 quarters · filed 2021-02-25 | $209.00K derived: sum of 3 quarters · filed 2021-02-25 | $549.00K 10-K · filed 2021-02-25 | ||||||||||||||||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $16.00K derived: sum of 2 quarters · filed 2020-11-04 | $356.00K 10-Q · filed 2020-11-04 | $356.00K derived: sum of 4 quarters · filed 2020-11-04 | ||||||||||||||||
| 2019-06-30 | $16.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $356.00K 10-Q · filed 2020-08-05 | $356.00K derived: sum of 3 quarters · filed 2020-08-05 | $235.00K derived: sum of 4 quarters · filed 2020-08-05 | ||||||||||||||||
| 2019-03-31 | $340.00K 10-Q · filed 2020-05-06 | $340.00K derived: sum of 2 quarters · filed 2020-05-06 | $219.00K derived: sum of 3 quarters · filed 2020-05-06 | $178.00K derived: sum of 4 quarters · filed 2020-05-06 | ||||||||||||||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$121.00K derived: sum of 2 quarters · filed 2020-02-25 | -$162.00K derived: sum of 3 quarters · filed 2020-02-25 | -$200.00K 10-K · filed 2020-02-25 | ||||||||||||||||
| 2018-09-30 | -$121.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | -$162.00K derived: sum of 2 quarters · filed 2018-11-01 | -$200.00K 10-Q · filed 2018-11-01 | -$222.00K derived: sum of 4 quarters · filed 2019-02-26 | ||||||||||||||||
| 2018-06-30 | -$41.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | -$79.00K 10-Q · filed 2018-08-02 | -$101.00K derived: sum of 3 quarters · filed 2019-02-26 | -$142.00K derived: sum of 4 quarters · filed 2019-02-26 | ||||||||||||||||
| 2018-03-31 | -$38.00K 10-Q · filed 2018-05-09 | -$60.00K derived: sum of 2 quarters · filed 2019-02-26 | -$101.00K derived: sum of 3 quarters · filed 2019-02-26 | -$187.00K derived: sum of 4 quarters · filed 2019-02-26 | ||||||||||||||||
| 2017-12-31 | -$22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | -$63.00K derived: sum of 2 quarters · filed 2019-02-26 | -$149.00K derived: sum of 3 quarters · filed 2019-02-26 | -$188.00K 10-K · filed 2019-02-26 | ||||||||||||||||
| 2017-09-30 | -$41.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | -$127.00K derived: sum of 2 quarters · filed 2018-11-01 | -$166.00K 10-Q · filed 2018-11-01 | -$220.00K derived: sum of 4 quarters · filed 2019-02-26 | ||||||||||||||||
| 2017-06-30 | -$86.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | -$125.00K 10-Q · filed 2018-08-02 | -$179.00K derived: sum of 3 quarters · filed 2019-02-26 | -$724.00K derived: sum of 4 quarters · filed 2019-02-26 | ||||||||||||||||
| 2017-03-31 | -$39.00K 10-Q · filed 2018-05-09 | -$93.00K derived: sum of 2 quarters · filed 2019-02-26 | -$638.00K derived: sum of 3 quarters · filed 2019-02-26 | -$486.00K derived: sum of 4 quarters · filed 2019-02-26 | ||||||||||||||||
| 2016-12-31 | -$54.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | -$599.00K derived: sum of 2 quarters · filed 2019-02-26 | -$447.00K derived: sum of 3 quarters · filed 2019-02-26 | -$361.00K 10-K · filed 2019-02-26 | ||||||||||||||||
| 2016-09-30 | -$545.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$393.00K derived: sum of 2 quarters · filed 2017-11-07 | -$307.00K 10-Q · filed 2017-11-07 | -$1.13M derived: sum of 4 quarters · filed 2018-02-27 | ||||||||||||||||
| 2016-06-30 | $152.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $238.00K 10-Q · filed 2017-08-07 | -$584.00K derived: sum of 3 quarters · filed 2018-02-27 | -$778.00K derived: sum of 4 quarters · filed 2018-02-27 | ||||||||||||||||
| 2016-03-31 | $86.00K 10-Q · filed 2017-05-10 | -$736.00K derived: sum of 2 quarters · filed 2018-02-27 | -$930.00K derived: sum of 3 quarters · filed 2018-02-27 | -$936.00K derived: sum of 4 quarters · filed 2018-02-27 | ||||||||||||||||
| 2015-12-31 | -$822.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$1.02M derived: sum of 2 quarters · filed 2018-02-27 | -$1.02M derived: sum of 3 quarters · filed 2018-02-27 | -$150.00K 10-K · filed 2018-02-27 | ||||||||||||||||
| 2015-09-30 | -$194.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2016-11-09 | -$200.00K derived: sum of 2 quarters · filed 2016-11-09 | $672.00K 10-Q · filed 2016-11-09 | $392.00K derived: sum of 4 quarters · filed 2017-03-16 | ||||||||||||||||
| 2015-06-30 | -$6.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2016-08-10 | $866.00K 10-Q/A · filed 2016-08-10 | $586.00K derived: sum of 3 quarters · filed 2017-03-16 | $1.19M derived: sum of 4 quarters · filed 2017-03-16 | ||||||||||||||||
| 2015-03-31 | $872.00K 10-Q · filed 2016-05-09 | $592.00K derived: sum of 2 quarters · filed 2017-03-16 | $1.19M derived: sum of 3 quarters · filed 2017-03-16 | $1.41M derived: sum of 4 quarters · filed 2017-03-16 | ||||||||||||||||
| 2014-12-31 | -$280.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $319.00K derived: sum of 2 quarters · filed 2017-03-16 | $533.00K derived: sum of 3 quarters · filed 2017-03-16 | $615.00K 10-K · filed 2017-03-16 | ||||||||||||||||
| 2014-09-30 | $599.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $813.00K derived: sum of 2 quarters · filed 2015-11-09 | $895.00K 10-Q · filed 2015-11-09 | $130.00K 10-Q · filed 2014-11-10 | $360.00K 10-Q · filed 2014-11-10 | |||||||||||||||
| 2014-06-30 | $214.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $296.00K 10-Q · filed 2015-08-10 | $131.00K 10-Q · filed 2014-08-11 | $361.00K 10-Q · filed 2014-08-11 | ||||||||||||||||
| 2014-03-31 | $82.00K 10-Q · filed 2015-05-11 | $230.00K 10-Q · filed 2014-05-12 | ||||||||||||||||||
| 2013-12-31 | $230.00K 10-K · filed 2014-03-03 | |||||||||||||||||||
| 2013-09-30 | $230.00K 10-Q · filed 2013-11-12 | |||||||||||||||||||
| 2013-06-30 | $230.00K 10-Q · filed 2013-08-09 | |||||||||||||||||||
| 2013-03-31 | $230.00K 10-Q · filed 2013-05-10 | |||||||||||||||||||
| 2012-12-31 | $230.00K 10-K · filed 2013-03-18 | |||||||||||||||||||
| 2012-09-30 | $230.00K 10-Q · filed 2012-11-09 | |||||||||||||||||||
| 2012-06-30 | $230.00K 10-Q · filed 2012-08-09 | |||||||||||||||||||
| 2012-03-31 | $230.00K 10-Q · filed 2012-05-10 | |||||||||||||||||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $0.00 derived: sum of 2 quarters · filed 2014-03-03 | $0.00 derived: sum of 3 quarters · filed 2014-03-03 | -$87.00K 10-K · filed 2014-03-03 | $230.00K 10-K · filed 2012-03-15 | |||||||||||||||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $0.00 derived: sum of 2 quarters · filed 2012-11-09 | -$87.00K 10-Q · filed 2012-11-09 | -$174.00K derived: sum of 4 quarters · filed 2013-03-18 | $230.00K 10-Q · filed 2011-11-04 | |||||||||||||||
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$87.00K 10-Q · filed 2012-08-09 | -$174.00K derived: sum of 3 quarters · filed 2013-03-18 | $230.00K 10-Q · filed 2011-08-04 | ||||||||||||||||
| 2011-03-31 | -$87.00K 10-Q · filed 2012-05-10 | -$174.00K derived: sum of 2 quarters · filed 2013-03-18 | ||||||||||||||||||
| 2010-12-31 | -$87.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | -$267.00K 10-K · filed 2013-03-18 | ||||||||||||||||||
| 2010-09-30 | -$180.00K 10-Q · filed 2011-11-04 | |||||||||||||||||||
| 2009-12-31 | $36.00K 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |